Pro Dex Inc (PDEX) stock
PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/306% below fair value
$65.66−1.76 (-2.61%)
Close on Nov 13, 2026Market cap $210.11MP/E 18.1Yield –
Pro Dex total assets
Total assets on the balance sheet at the end of each period.
Pro Dex's total assets was $76.59M at Sep 30, 2026. For fiscal 2026 it was $74.51M, up 21.8% from the year before. Over ten years it grew 20.9% a year on average. The highest annual figure on record is $74.51M in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $74.51M | +21.8% |
| FY2025 | Jun 30, 2025 | $61.19M | +16.6% |
| FY2024 | Jun 30, 2024 | $52.48M | +1.3% |
| FY2023 | Jun 30, 2023 | $51.82M | +5.6% |
| FY2022 | Jun 30, 2022 | $49.09M | +21.7% |
| FY2021 | Jun 30, 2021 | $40.32M | +29.5% |
| FY2020 | Jun 30, 2020 | $31.13M | +22.0% |
| FY2019 | Jun 30, 2019 | $25.52M | +28.1% |
| FY2018 | Jun 30, 2018 | $19.92M | +21.8% |
| FY2017 | Jun 30, 2017 | $16.35M | +46.7% |
| FY2016 | Jun 30, 2016 | $11.15M | -10.9% |
| FY2015 | Jun 30, 2015 | $12.52M | +6.9% |
| FY2014 | Jun 30, 2014 | $11.71M | +10.5% |
| FY2013 | Jun 30, 2013 | $10.60M | -17.4% |
| FY2012 | Jun 30, 2012 | $12.82M | -17.6% |
| FY2011 | Jun 30, 2011 | $15.56M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $76.59M | +19.1% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $74.51M | +21.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $74.98M | +16.7% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $62.26M | +3.1% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $64.30M | +18.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $61.19M | +16.6% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $64.27M | +27.2% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $60.37M | +17.4% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $54.31M | +9.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $52.48M | +1.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $50.55M | -2.2% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $51.43M | -0.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $49.59M | -0.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $51.82M | +5.6% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $51.69M | +14.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $51.88M | +19.7% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $49.86M | +16.1% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $49.09M | +21.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $45.22M | +5.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $43.33M | +10.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $42.93M | +36.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $40.32M | +29.5% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $43.04M | +52.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $39.06M | +36.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $31.45M | +12.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $31.13M | +22.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $28.23M | +10.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $28.73M | +19.6% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $27.97M | +11.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $25.52M | +28.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $25.63M | +31.6% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $24.03M | +27.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $25.19M | +38.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $19.92M | +21.8% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $19.48M | +26.6% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $18.81M | +25.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $18.17M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $16.35M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $15.39M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $15.03M | – |
See a number that looks wrong?